ABSTRACT
I. Introduction Lung transplantation brings with it a plethora of infectious issues, which are a direct result of an immunocompromised state secondary to a multiprong approach used to disrupt immunity. Lungs are the only organs that are under a constant onslaught of environmental pathogens. Pulmonary fungal infections are not only a cause of major mortality but also of continued morbidity in association with chronic graft loss in lung transplant (LT) recipients.
